Search Results
Apr 20, 2026, 09:30 ET iGarden Sweeps the 2026 MUSE Design Awards. Three New Products, Three Platinum Wins
without installation or external wiring—bringing both athletic training and leisure experiences into everyday environments.iGarden Lawn Mower L AWD Series redefines robotic lawn care with 4WD mobility, 360° LiDAR and AI vision, and TurboSilence™ adaptive energy management. Operating without boundary
More news about: iGarden
Apr 20, 2026, 09:30 ET Hesai Unveils Picasso 6D Full-Color SPAD-SoC, Next-Gen ETX, and Innovations in Spatial Intelligence and Physical AI
lidar platform built on the Picasso architecture, the next-generation ETX represents a major step forward in high-performance perception. Designed for L3 and above autonomous driving, it combines longer range, higher resolution, and full-color perception in a flexible architecture with 1,080, 2,160, and
More news about: Hesai Technology
Apr 20, 2026, 09:07 ET Zoomlion accélère le déploiement mondial de pelles hydrauliques de très grande taille et de solutions minières intelligentes
Chine, 20 avril 2026 /PRNewswire/ -- Zoomlion Heavy Industry Science & Technology Co, Ltd. (« Zoomlion » ou l'« entreprise » ; 1157.HK) a dévoilé les dernières avancées de son portefeuille de pelles hydrauliques de très grande taille et de sa gamme d'équipements
More news about: Zoomlion
Apr 20, 2026, 09:00 ET Kyndryl Named a Leader in 2026 ISG Provider Lens™ Mainframes - Services and Solutions
support discrete projects and multi-year transformations, addressing both infrastructure and applications across various hosting models," said Pedro L. Bicudo Maschio, ISG distinguished analyst and author. He added that Kyndryl's MFaaS and agentic-AI capabilities offer customers predictable economics,
More news about: Kyndryl
Apr 20, 2026, 08:48 ET The Province of Chubut announces the commencement of its Offer to Purchase for Cash its U.S. Dollar Step Up Secured Amortizing Notes due 2030
ISIN 144A: US17127LAA35/ CUSIP 144A: 17127L AA3 / ISIN RegS: USP25619AB67/
More news about: The Province of Chubut
Apr 20, 2026, 08:00 ET Sapience Therapeutics Presents First Clinical Results from Phase 2 Study of ST316, First-in-Class β-catenin Antagonist, in Second-Line Colorectal Cancer at the American Association for Cancer Research (AACR) Annual Meeting 2026
Highly encouraging initial clinical results in second-line colorectal cancer (2L CRC): 47% objective response rate, disease control in 93% of patients TARRYTOWN, N.Y., April 20, 2026 /PRNewswire/
More news about: Sapience Therapeutics, Inc.
Apr 20, 2026, 07:30 ET 52-Week Topline Results from 16-Week Blinded Treatment Extension of REZOLVE-AA Demonstrate Deepening of Responses in Severe-to-Very-Severe Alopecia Areata with Rezpegaldesleukin
https://doi.org/10.1111/ddg.14689National Alopecia Areata FoundationAlhanshali L, Buontempo MG, Lo Sicco KI, Shapiro J. Alopecia Areata: Burden of Disease, Approach to Treatment, and Current Unmet Needs. Clin Cosmet Investig Dermatol.
More news about: Nektar Therapeutics
Apr 20, 2026, 07:30 ET TJ Biopharma Enters into Agreement with Biogen for Felzartamab Assets in the Greater China Region
in China (2025)]. Zhonghua Nei Ke Za Zhi. 2025 Oct 1;64(10):918-944. Chinese. doi: 10.3760/cma.j.cn112138-20250707-00396. PMID: 41083387.Tang L, Yao J, Kong X, Sun Q, Wang Z, Zhang Y, Wang P, Liu Y, Li W, Cui M, Zhen J, Xu D. Increasing prevalence of membranous nephropathy in patients with primary
More news about: TJ Biopharma
Apr 20, 2026, 07:00 ET Nemphos Braue Elevates Matthew L. Allison to Counsel and Welcomes Corporate Associate Chloe R. Hill
its commitment to providing big-firm expertise and a tailored, business-focused approach to legal counsel.Matthew L. Allison Promoted to CounselMatthew L. Allison has been promoted to Counsel in recognition of his extensive experience advising clients on corporate transactions, mergers
More news about: Nemphos Braue, LLC
Apr 20, 2026, 06:45 ET U.S. FDA Grants Priority Review to sBLA for PADCEV™ + Keytruda® as Perioperative Treatment for Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility
countries around the world. PADCEV is also approved as a single agent for the treatment of adult patients with la/mUC who have previously received a PD-1/PD-L1 inhibitor and platinum-containing chemotherapy or are ineligible for cisplatin-containing chemotherapy and have previously received one or more prior
More news about: Astellas Pharma Inc.
Apr 20, 2026, 06:00 ET Top 5 Gundry MD Total Restore Reviews: Will It Improve Your Gut Health?
Traditionally used to help soothe the digestive tract and support the growth of beneficial gut bacteria, helping promote a balanced gut environment.L-Glutamine – An essential amino acid known for its role in maintaining a strong intestinal lining, supporting healthy digestion, and helping manage occasional
More news about: Gundry MD
Apr 20, 2026, 03:00 ET Narwal dévoile Flow 2 : un chef-d'œuvre d'innovation utile et d'entretien domestique sans effort
stérilisation thermique à 100°C, accessoire anti-calcaire pour protéger le circuit d'eau, distributeur automatique de détergent, sac à poussière de 2,4 L (jusqu'à 120 jours sans maintenance) ou bien encore séchage à air chaud à 60°C.Une version compacte (28 cm de hauteur) est également disponible
More news about: Narwal
Apr 20, 2026, 02:30 ET New Combination Therapy for Advanced Small Cell, Lung Cancer Approved in Australia and Singapore
2026].[6] Huang Y, Xu Z, Bao L. Front Immunol. 2025 Sep 23;16:1658740.[7]
More news about: Specialised Therapeutics
Apr 19, 2026, 21:44 ET Tradewind Finance Sediakan Fasilitas Anjak Piutang Ekspor Tanpa Hak Regres Sebesar AS$2,5 Juta Untuk Eksportir Kabel Asal Vietnam
kabel selama lebih dari 30 tahun di Vietnam. Selama sebagian besar periode tersebut, perusahaan mengandalkan pembayaran di muka dan Letter of Credit (L/C) untuk mengelola transaksi ekspornya.Seiring meningkatnya persaingan pasokan kabel di seluruh dunia, pembeli mulai memerlukan metode pembayaran
More news about: Tradewind Finance
Apr 19, 2026, 21:44 ET Tradewind Finance Cung Cấp Gói Tài Trợ Bao Thanh Toán Xuất Khẩu Miễn Truy Đòi Trị Giá 2,5 Triệu USD Cho Doanh Nghiệp Sản Xuất Cáp Tại Việt Nam
với hơn 30 năm lịch sử hoạt động tại Việt Nam. Trong phần lớn thời gian đó, công ty phụ thuộc vào phương thức thanh toán trả trước và thư tín dụng (L/C) để quản lý các giao dịch xuất khẩu.Tuy nhiên, khi sự cạnh tranh trong chuỗi cung ứng cáp toàn cầu gia tăng, các bên mua bắt đầu yêu cầu điều
More news about: Tradewind Finance
Apr 19, 2026, 20:15 ET CStone Presented Preclinical Data for Three Novel or Differentiated ADCs at AACR 2026, Including CS5007 (EGFR/HER3)
amplifies key signaling cascades—including ErbB2, PI3K, FAK/Akt, and c-Met—thereby driving tumor progression. It also upregulates the expression of PD-L1 and mediates anti-PD-1 resistance via MEK/ERK signaling.CS5006 is a novel ADC targeting ITGB4, composed of a humanized anti-ITGB4 IgG1 antibody
More news about: CStone Pharmaceuticals
Apr 19, 2026, 13:19 ET Lundbeck presents new data at AAN 2026 highlighting real-world changes in migraine-related cognitive symptoms after starting VYEPTI® (eptinezumab)
a patient-centered approach. J Neurol. 2023;270(12):5692-5710.[5] Cohen, F., Brooks, C. V., Sun, D., Buse, D. C., Reed, M. L., Fanning, K. M., & Lipton, R. B. (2024). Prevalence and burden of migraine in the United States: A systematic review. Headache, 64(5),
More news about: H. Lundbeck A/S
Apr 18, 2026, 19:44 ET BREAKTHROUGH PRIZE ANNOUNCES 2026 LAUREATES
particles on a lattice.Dillon Brout, J. Colin Hill, Mathew Madhavacheril, Maria Vincenzi, Daniel Scolnic, and W. L. Kimmy Wu have gleaned powerful new results from the two most important tools for measuring the expansion and composition of the Universe: the cosmic
More news about: Breakthrough Prize
Apr 18, 2026, 04:31 ET Tech TAILG. Leading Globally: TAILG Showcases at the 139th Canton Fair
including electric motorcycles, e-bikes, electric bicycles, and electric tricycles, meeting diverse mobility needs across global markets.The F91 Ultra-L fast-charging model made a key appearance, featuring automotive-grade fast-charging technology and an integrated "vehicle + charging station" solution.
More news about: TAILG
Apr 17, 2026, 21:10 ET Okuma America Corporation recibe premios por su programa de capacitación en Rowan-Cabarrus Community College
herramienta CNC de Okuma para la formación práctica, entre las que se incluyen una GENOS M460V-5AX (centro de mecanizado vertical de cinco ejes), una GENOS L3000-e MYW (torno horizontal), una MA-4000H (centro de mecanizado horizontal) y una MULTUS B400II (torno multitarea)."Ha sido un honor para nosotros
More news about: Okuma America Corporation
Apr 17, 2026, 20:30 ET Antengene Presents Three Novel Programs at AACR 2026, Highlighting Next-Generation ADC and AnTenGager® TCEs
Details of the Poster Presentation:ATG-125 (B7-H3 x PD-L1 bispecific ADC)Title: ATG-125, a novel B7H3 x PD-L1 bispecific antibody-drug conjugate, demonstrates potent antitumor efficacy by dual targeting of immune evasion and
More news about: Antengene Corporation Limited
Apr 17, 2026, 20:29 ET Banistmo Announces Expiration and Results of its Consent Solicitation relating to its 4.250% Senior Notes due 2027
CUSIP Nos. 06034L AB6 / P15383 CD5PANAMA CITY, April 17, 2026 /PRNewswire/ -- Banistmo, S.A. ("Banistmo") announces the expiration and results of its previously announced consent solicitation
More news about: Banistmo, S.A.
Apr 17, 2026, 16:15 ET UNITED BANCSHARES, INC. ANNOUNCES FIRST QUARTER 2026 RESULTS AND $0.25 DIVIDEND
Robert L. BenrothAnthony M. V. EramoHerbert H. Huffman IIIKevin L. Lammon
More news about: United Bancshares, Inc.
Apr 17, 2026, 16:01 ET New Clinical and Preclinical Data for Investigational Candidate Zidesamtinib Presented at AACR Annual Meeting 2026
Kaplan-Meier estimates. e Responses also observed in pts with ROS1 D2033N (n=1) and L2086F (n=1).f Includes patients with measurable (≥5mm) CNS lesions by BICR at baseline.The
More news about: Nuvalent, Inc.
Apr 17, 2026, 15:00 ET Meiji Holdings Co., Ltd. Highlights that Yogurt Containing Bacteria Metabolite Shows a Tendency Toward Higher Response When Added to Immune Checkpoint Inhibitor Therapy in People Living with Non-small Cell Lung Cancer
with an ORR of 43.3% (vs 35.1% in historical control) and a DCR of 73.3% (vs 64.4%).Among the 15 pembrolizumab-treated patients with high PD-L1 expression (TPS ≥50%), outcomes versus historical control were favorable, with an ORR of 58.3% (vs 39.5%) and a DCR of 91.7% (vs 77.6%).In the
More news about: Meiji Holdings Co Ltd